Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

SNY Sanofi

48,72

-1,38 (-2,75%)

Zuletzt aktualisiert: 20:38:14

Verzögert um 15 Minuten

Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives orphan drug designation (ODD). A

To read the full story on AllPennyStocks.com, click here.

Sanofi (NASDAQ:SNY)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Sanofi Charts.

Sanofi (NASDAQ:SNY)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Sanofi Charts.

News Sanofi

Southwest Shares Tumble 9.6% Post $231 Million 1Q Loss, AstraZeneca Surges on 19% Annual Increase, and More on Earnings
Donnerstag 25 April 2024 (2 Wochen vor) • IH Market News

Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More
Freitag 19 April 2024 (3 Wochen vor) • IH Market News

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
Freitag 23 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Freitag 23 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)
Donnerstag 25 Januar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 23 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update
Dienstag 23 Januar 2024 (4 Monate vor) • Dow Jones News

Wall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and More
Dienstag 23 Januar 2024 (4 Monate vor) • IH Market News

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
Dienstag 23 Januar 2024 (4 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Sanofi News-Artikel

Invesco QQQ Trust Series 1

JP Morgan Chase

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen